Literature DB >> 7875321

Cross-linking of galectin 3, a galactose-binding protein of mammalian cells, by tissue-type transglutaminase.

B Mehul1, S Bawumia, R C Hughes.   

Abstract

The 30 kDa beta-galactoside-binding protein of baby hamster kidney (BHK) cells [Mehul et al. (1994), J. Biol. Chem. 269, 18250-18258] homologous to galectin 3, a widely distributed mammalian lectin, has been found to be a substrate for tissue type transglutaminase, as shown by the incorporation in a calcium- and time-dependent manner of 5-(biotinamido) pentylamine in the presence of guinea pig liver transglutaminase. The amino-terminal domain of hamster galectin 3, which is a repetitive sequence rich in glutamine, tyrosine, glycine and proline, is also an excellent substrate. A single lysine residue in the N-terminal domain is an essential requirement for transglutaminase-mediated oligomerization, and two equivalent glutamine residues present in identical sequence repeats within this domain appear to be involved as amine acceptors in cross-linking reactions. Transglutaminase-mediated cross-linking of galectin 3 to itself or to matrix components may be one mechanism for stabilisation of a multivalent binding form of the lectin in cell secretions or in extracellular matrices.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7875321     DOI: 10.1016/0014-5793(95)00100-n

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  18 in total

1.  Kinetic measurements of binding of galectin 3 to a laminin substratum.

Authors:  E A Barboni; S Bawumia; R C Hughes
Journal:  Glycoconj J       Date:  1999-07       Impact factor: 2.916

2.  Mathematical modeling of K-Ras nanocluster formation on the plasma membrane.

Authors:  Tianhai Tian; Sarah J Plowman; Robert G Parton; Yoel Kloog; John F Hancock
Journal:  Biophys J       Date:  2010-07-21       Impact factor: 4.033

3.  Galectin-3: A Harbinger of Reactive Oxygen Species, Fibrosis, and Inflammation in Pulmonary Arterial Hypertension.

Authors:  David J R Fulton; Xueyi Li; Zsuzsanna Bordan; Yusi Wang; Keyvan Mahboubi; R Daniel Rudic; Stephen Haigh; Feng Chen; Scott A Barman
Journal:  Antioxid Redox Signal       Date:  2019-03-29       Impact factor: 8.401

Review 4.  Diagnostic utility of galectin-3 in thyroid cancer.

Authors:  Connie G Chiu; Scott S Strugnell; Obi L Griffith; Steven J M Jones; Allen M Gown; Blair Walker; Ivan R Nabi; Sam M Wiseman
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  Galectin-3 Promotes ROS, Inflammation, and Vascular Fibrosis in Pulmonary Arterial Hypertension.

Authors:  Scott A Barman; Zsuzsanna Bordan; Robert Batori; Stephen Haigh; David J R Fulton
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation.

Authors:  Nathalie Ortega; Danielle J Behonick; Céline Colnot; Douglas N W Cooper; Zena Werb
Journal:  Mol Biol Cell       Date:  2005-03-30       Impact factor: 4.138

7.  Phenotypic expression in human monocyte-derived interleukin-4-induced foreign body giant cells and macrophages in vitro: dependence on material surface properties.

Authors:  Amy K McNally; James M Anderson
Journal:  J Biomed Mater Res A       Date:  2014-07-26       Impact factor: 4.396

8.  Alterations in galectin-3 expression and distribution correlate with breast cancer progression: functional analysis of galectin-3 in breast epithelial-endothelial interactions.

Authors:  Malathy P V Shekhar; Pratima Nangia-Makker; Larry Tait; Fred Miller; Avraham Raz
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

9.  Galectin-3 protein regulates mobility of N-cadherin and GM1 ganglioside at cell-cell junctions of mammary carcinoma cells.

Authors:  Cécile Boscher; Yu Zi Zheng; Ramya Lakshminarayan; Ludger Johannes; James W Dennis; Leonard J Foster; Ivan R Nabi
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

10.  K-ras nanoclustering is subverted by overexpression of the scaffold protein galectin-3.

Authors:  Ruby Shalom-Feuerstein; Sarah J Plowman; Barak Rotblat; Nicholas Ariotti; Tianhai Tian; John F Hancock; Yoel Kloog
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.